Last updated on May 2019

PANORAMA - Real World Molecular Testing Treatment Patterns and Clinical Outcomes EGFR Mutation-Positive NSCLC


Brief description of study

The objectives of this study are to assess molecular testing, treatment patterns, and associated outcomes among patients with EGFR (Epidermal Growth Factor Receptor) mutation-positive locally advanced or advanced NSCLC (Non-Small Cell Lung Cancer) who have progressed on or after EGFR-TKI (EGFR-Tyrosine Kinase Inhibitor) therapy post availability of a third-generation TKI (primary study cohort). Additionally, molecular testing and treatment patterns will be assessed among a secondary cohort of patients which will include patients diagnosed with de-novo EGFR T790M mutation-positive locally advanced or advanced NSCLC.

Clinical Study Identifier: NCT02777658

Find a site near you

Start Over

Research Site

Aschaffenburg, Germany
  Connect »

Research Site

Augsburg, Germany
  Connect »

Research Site

Bad Kreuznach, Germany
  Connect »

Research Site

Ballenstedt, Germany
  Connect »

Research Site

Bautzen, Germany
  Connect »

Research Site

Bottrop, Germany
  Connect »

Research Site

Dresden, Germany
  Connect »

Research Site

Duesseldorf, Germany
  Connect »

Research Site

Esslingen, Germany
  Connect »

Research Site

Frankfurt-Oder, Germany
  Connect »

Research Site

Freiburg i.Br., Germany
  Connect »

Research Site

Freital, Germany
  Connect »

Research Site

Gauting, Germany
  Connect »

Research Site

Georgsmarienhuette, Germany
  Connect »

Research Site

Goettingen, Germany
  Connect »

Research Site

Greifenstein, Germany
  Connect »

Research Site

Guestrow, Germany
  Connect »

Research Site

Guetersloh, Germany
  Connect »

Research Site

Halle-Saale, Germany
  Connect »

Research Site

Hamburg, Germany
  Connect »

Research Site

Hannover, Germany
  Connect »

Research Site

Heidenheim, Germany
  Connect »

Research Site

Hildesheim, Germany
  Connect »

Research Site

Kaiserslautern, Germany
  Connect »

Research Site

Karlsruhe, Germany
  Connect »

Research Site

Kempten, Germany
  Connect »

Research Site

Koblenz, Germany
  Connect »

Research Site

Krefeld, Germany
  Connect »

Research Site

Landshut, Germany
  Connect »

Research Site

Leipzig, Germany
  Connect »

Research Site

Loewenstein, Germany
  Connect »

Research Site

Ludwigsburg, Germany
  Connect »

Research Site

Moenchengladbach, Germany
  Connect »

Research Site

Muehlheim A.d. Ruhr, Germany
  Connect »

Research Site

Muenchen, Germany
  Connect »

Research Site

Muennerstadt, Germany
  Connect »

Research Site

Naunhof, Germany
  Connect »

Research Site

Neustadt a.R., Germany
  Connect »

Research Site

Nuernberg, Germany
  Connect »

Research Site

Offenburg, Germany
  Connect »

Research Site

Oldenburg, Germany
  Connect »

Research Site

Osnabrueck, Germany
  Connect »

Research Site

Porta Westfalica, Germany
  Connect »

Research Site

Ratingen, Germany
  Connect »

Research Site

Ravensburg, Germany
  Connect »

Research Site

Rosenheim, Germany
  Connect »

Research Site

Rostock, Germany
  Connect »

Research Site

Schorndorf, Germany
  Connect »

Research Site

Stolberg, Germany
  Connect »

Research Site

Stuttgart, Germany
  Connect »

Research Site

Twistringen, Germany
  Connect »

Research Site

Voelklingen, Germany
  Connect »

Research Site

Westerstede, Germany
  Connect »

Research Site

Wiesbaden, Germany
  Connect »

Research Site

Wuerselen, Germany
  Connect »

Research Site

Wuerzburg, Germany
  Connect »

Research Site

Muehlheim a.d. Ruhr, Germany
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.